Detalhe da pesquisa
1.
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Hum Mutat
; 42(3): 290-299, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326660
2.
Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.
Genet Mol Biol
; 39(2): 168-77, 2016 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27192127
3.
Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational Profiling.
Cancers (Basel)
; 12(10)2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007869
4.
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Cancers (Basel)
; 12(9)2020 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971741
5.
Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping.
J Oncol
; 2019: 8393769, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31485228
6.
Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.
Oncotarget
; 7(20): 28920-34, 2016 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27081085
7.
Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Oncotarget
; 7(49): 80465-80481, 2016 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27741520